loss

(redirected from sensorineural hearing loss)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Loss

The opposite of gain.
Copyright © 2012, Campbell R. Harvey. All Rights Reserved.

Loss

Extracting less money from a transaction than one put into it. For example, a business' expenses may be $1 million for a year but it may only take in $800,000 in revenue. In such a case, the business has suffered a $200,000 loss. This is not always bad; most businesses lose money in the first few years of operation and this can reduce their tax liability when they do make a profit. However, losses over an extended period of time ultimately result in failure. See also: Gain, Paper Loss, Loss Carryforward, Loss Carryback.
Farlex Financial Dictionary. © 2012 Farlex, Inc. All Rights Reserved

loss

The deficiency of the amount received as opposed to the amount invested in a transaction. Compare gain. See also net loss.
Wall Street Words: An A to Z Guide to Investment Terms for Today's Investor by David L. Scott. Copyright © 2003 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved. All rights reserved.

loss

the shortfall between a firm's sales revenues received from the sale of its products and the total costs incurred in producing the firm's output (see BREAK-EVEN ANALYSIS). Losses may be of a temporary nature occasioned by, for example, a downturn in demand (see BUSINESS CYCLE) or due to an exceptional level of expenditures (such as the launch of a series of new products). Short-term losses are usually financed by a firm running down its RESERVES or by an increase in borrowings. Losses which are sustained over time typically arise from a firm's poor competitive position in a market (see COMPETITIVE ADVANTAGE), and unless competitiveness can be restored market exit or DIVESTMENT may be the only practical way of remedying the situation. See MARKET SYSTEM.
Collins Dictionary of Business, 3rd ed. © 2002, 2005 C Pass, B Lowes, A Pendleton, L Chadwick, D O’Reilly and M Afferson

loss

the difference that arises when a firm's TOTAL REVENUES are less than TOTAL COSTS. In the SHORT RUN, where firms’ total revenues are insufficient to cover VARIABLE COSTS, then they will exit from the market unless they perceive this situation as being temporary. In these circumstances, where firms’ total revenues are sufficient to cover variable costs and make some CONTRIBUTION towards FIXED COSTS, then they will continue to produce despite overall losses. In the LONG RUN, however, unless firms’ revenues are sufficient to cover both variable and fixed costs, then their overall losses will cause them to exit from the market. See MARKET EXIT, LOSS MINIMIZATION, PROFIT-AND-LOSS ACCOUNT.
Collins Dictionary of Economics, 4th ed. © C. Pass, B. Lowes, L. Davies 2005
References in periodicals archive ?
Treatment of idiopathic sudden sensorineural hearing loss with antiviral therapy: a prospective, randomized, double-blind clinical trial.
Sudden sensorineural hearing loss: risk factors and comorbidities.
Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis.
In our study, we conclude that carbogen therapy is a beneficial addition to steroids in the treatment of sudden sensorineural hearing loss.
Acoustic neuroma is one of the risk factors of sudden sensorineural hearing loss (SSHL) (3-15%).
This means that anything that damages nerve cells will damage the connections between hair cells and the auditory centers of the brain, leading to sensorineural hearing loss. These factors include oxidative stress and resulting inflammatory changes, as well as mitochondrial dysfunction and, eventually, cell death.
Bilateral versus unilateral sudden sensorineural hearing loss. Otolaryngol Head Neck Surg 2007;136:87-91.
Keywords * Sensorineural hearing loss * Renal insufficiency * Postpartum period
Sensorineural hearing loss (SNHL) is a major cause of hearing loss in children which leads to serious challenges not only for the child and the family but also for the physician since the diagnosis of the disease is difficult and there are limited treatment and rehabilitation options.2
Huang, "Experimental study oflocal inner ear gene therapy for controlling autoimmune sensorineural hearing loss," BioMed Research International, vol.
PTA showed moderate sensorineural hearing loss in the right ear with an average PTA threshold of 49.54 dB HL and normal hearing in the left side (Figure 3(a)).
Results: Pure tone audiometry (PTA) of 448 industry workers showed that 39(8.71%) had sensorineural hearing loss and 8(1.78%) had conductive hearing loss.